Defying the Virus Sarah-Maria Fendt and Markus Ralser Journal

Total Page:16

File Type:pdf, Size:1020Kb

Defying the Virus Sarah-Maria Fendt and Markus Ralser Journal WINTER 2020/2021 ISSUE 44 How EMBO Members and their colleagues have risen to the scientific challenge Defying the virus PAGES 2-3 EMBO Gold Medal 2020 A look at the first nine months Sarah-Maria Fendt and Journal-independent Markus Ralser peer review PAGE 7 PAGE 11 Meeting report Excellence in the life sciences Homecoming Gender roles in academia The new EMBO Members Experiences from EMBO Installation Grantees PAGE 10 PAGE 13 PAGE 12 www.embo.org TABLE OF CONTENTS EMBO NEWS Defying the virus EMBO Member rising to the scientific challenge Pages 3-4 Papers, preprints, and free lunches Interview with EMBO Head of Scientific Publishing, Bernd Pulverer Page 5 Promoting best practice in European science Meeting report Obituary Reflections on ways to tackle scientific Gender roles and their impact in academia Hermann Bujard (1934–2020) – pioneering misconduct Page 10 researcher and visionary science politician Page 16 Page 6 SDash: the SourceData dashboard Accelerating collaboration Page 11 In contrast to the HCA, the group Defying the virus leaders responsible for setting up and running the Vienna Biocenter’s Across the world, scientists and clinicians have combined in extraordinary impressively efficient SARS-CoV-2 efforts to help fight the COVID-19 pandemic. Three members of the EMBO testing programme had no prior experience in community tell how they and their colleagues have risen to this scientific the field, but simply felt that they needed to help. “We had the instruments, we had extensive Around the world challenge. EMBO Gold Medal 2020 expertise in molecular biology, and we thought Recent EMBO Global Activities together with we should pool our brainpower and equipment,” Sarah-Maria Fendt and Markus Ralser awarded By Kathy Weston Associate Member States says one of them, Andrea Pauli. Page 7 Review Commons: A look at the first Page 17 In her role as co-founder of the are far easier to catch. Due to the public health Three parallel initiatives were set up: an RT-qPCR nine months Human Cell Atlas (HCA), EMBO implications, the results were fast-tracked into pipeline for in-house testing and monitoring, led by Journal-independent peer review EMBO community Member and Gold Medallist Sarah print in a much-cited paper in April 2020. Johannes Zuber, and also involving Stefan Ameres; Updates from across Europe Teichmann coordinates a network More recent data show there is good concord- next generation sequencing, led by Ulrich Elling, Page 11 Pages 18-25 of hundreds of researchers around the world. As ance between the consortium’s predictions of Luisa Cochella and Alex Stark; and RT-LAMP, led the first ominous hints that SARS-CoV-2 was no where the virus would enter, and where it is by Julius Brennecke and Pauli. Interestingly, all Installation grants Awards and publications ordinary coronavirus appeared in early 2020, the actually found. “A good example is if you map seven are either EMBL alumni, present or past © Ine Dehandschutter © Homecoming - experiences from grantees Achievements and papers by members of the HCA community mobilised. “If you have a pre- the oral cavity from healthy donors and COVID- EMBO Young Investigators, or EMBO Members. Page 12 EMBO community existing community,” Teichmann says, “people 19 patients,” says Teichmann. “There are cells in They were joined by many other volunteers from Page 26 know each other, and they are very willing to the salivary glands that have high expression of the Vienna Biocenter research community. EMBO Membership collaborate”. From her laboratory at the Wellcome ACE2, and when we stain in tissue sections you Neither Pauli nor Brennecke had worked on Sanger Institute in Cambridge, Teichmann asked can see the virus sitting there.” anything related to LAMP (loop-mediated isother- her fellow researchers to use their published and To accompany their ongoing COVID-19 work, mal amplification) technology before. “I’m a “The award highlights that our research unpublished data to generate a map delineating the HCA community now maintains an open zebrafish embryologist and Julius works on RNA on metabolism and metastasis THE where in the body a panel of genes involved in access data portal, containing reference data from biology in flies, and to be honest, I didn’t even know formation is important” EMBO viral uptake was expressed. many more healthy tissues, together with single what LAMP was in March!” Pauli laughs. However, JOURNAL Interview with EMBO Gold Medallist It soon became clear from the pooled data that cell mapping of patient sample data, and spatial LAMP proved to be the best solution to developing Sarah-Marie Fendt one of the reasons for SARS-CoV-2’s rapid trans- mapping data from infected post-mortem tissue. a cheap and robust assay that could also be used in Page 8 missibility was the presence of the viral receptor The portal has become an invaluable resource, lower- and middle-income countries, where uncer- ACE2 and its associated protease TMPRSS2 on accessed tens of thousands of times. “It’s really tain supply chains and limited equipment make cells in the nose, mouth, upper airways and eyes; helped me get through this terrible year to know testing for SARS-CoV-2 especially challenging. this may explain why some respiratory viruses that we’ve been able to contribute something The assay costs less than 1€ per reaction, and Lifetime honour for 63 leading scientists like SARS-CoV-2 and influenza, whose receptors useful,” Teichmann says. only requires simple reagents and a waterbath Pages 13-14 are more highly expressed in the upper airways, set at 63ºC. An open-access version with home- © Janie Airey © Fresh from EMBO Press made enzymes is available, and Pauli hopes it Four of EMBO Press‘ latest publications at will be adopted not only in Austria, where diag- EMBO Members in the spotlight a glance Surprising moments that influenced their nostics labs and hospitals are now recommended Page 27 research “People know each other, to use it for testing, but worldwide. Page 15 Of the testing programme in general, Pauli EMBO events and they are very willing emphasizes that it was a team effort: “The whole Upcoming courses, workshops and courses campus has come together, from the directors, Page 28 to collaborate” “It feels great that metabolism is back particularly Harald Isemann (managing direc- tor of the IMP), to the students and technicians in focus” Sarah Teichmann running the assays. To some extent, the pandem- Interview with EMBO Gold Markus Ralser ic pushed us apart, but this project has really Page 9 brought us together.” photo courtesy of Sebastian Nevols 2 EMBOencounters | Winter 2020/2021 | [email protected] ©2020 EMBO ©2020 EMBO EMBOencounters | Winter 2020/2021 | [email protected] 3 EMBO NEWS EMBO NEWS In addition to his academic research, Vivier is also Chief Scientific Officer of Innate Pharma, Papers, preprints, and free lunches which had acquired Avdoralimab, an anti-C5a drug which had already passed phase 1 trials, Biologist Bernd Pulverer, Head of Scientific Publication at EMBO, discusses papers, some years previously. Aided by a French govern- preprints, academic presses, and the curse of the journal impact factor ment grant, Innate has provided the drug gratis to be tested against placebo in an ongoing Interview conducted by Thiago Carvalho Photo courtesy of IMP/Benedikt Mandl Photo courtesy of IMP/Benedikt double-blind randomised trial. Results are yet to be published, but Vivier is cautiously opti- Let’s jump right in. Why isn’t The EMBO Journal a mistic. “This is a potential path,” he says. “I’m fully open access journal? not saying that it’s definitely going to work—it That’s a very good question, because we have may not—but we may provide some treatments three open access journals, and one does wonder for patients who need them. And that would why they are not all open access. The reason is that be extraordinary.” our journals are quite expensive because they are highly selective and because the selection is based on in-depth editorial- and peer-review. It costs about 10,000 euros to produce a single published article. In the traditional open access model, the Life science author pays directly from whatever source they researchers’ efforts can find, and often this would unfortunately be “The pandemic pushed us their research budgets. This increasingly is flip- apart, but this project has to fight ping to a model where institutions or funders pay. In the institutional subscription model that The really brought us together” COVID-19 EMBO Journal and EMBO Reports have, this cost is distributed to many more readers. Andrea Pauli In April 2020, EMBO invited its 1800 Members Bernd Pulverer and 150 Young Investigators to report on Why do open access fees vary between different any efforts they or their institutions are From left to right: Ulrich Elling, Luisa Cochella, Johannes Zuber, Stefan Ameres, Alexander Stark EMBO Press publications? making to help fight the ongoing COVID- (at rear), Harald Isemann, Andrea Pauli, and Julius Brennecke. We’re trying to price our open access journals “Do not use journal-based metrics, such as journal Springer Nature, where at the end of the day what- 19 pandemic. We received responses from at an equitable level, and we are cross-financing impact factors, as a surrogate measure of the qual- ever project you do has to have a profit-compati- close to 400 scientists, of which 328 reported these journals from our subscription journals. ity of individual research articles, to assess an indi- ble business plan. Three examples of projects that SARS-CoV-2-related activities of their own Five years ago, EMBO Member 40 molecules for which drugs had already been That’s why we’ve kept two journals hybrid, and vidual scientist’s contributions, or in hiring, promo- don’t have a business model are preprints, set research groups, of their institutions, or their Eric Vivier co-founded Marseille developed in other contexts.
Recommended publications
  • Master's Position in Plant Molecular Biology
    Bachmair Lab Master’s position in plant molecular biology About the Bachmair lab Focus of the Bachmair lab lies on the biochemical and cell biological analysis of protein turnover driven by amino-terminal degradation signals. The biological context is how plants respond to environmental stimuli such as heat, flooding, or salt stress. Additional information can be found on the group page of the Bachmair lab. About the research project The applicant shall analyze protein turnover that depends on amino-terminal degradation signals. Firstly, expression of plant ubiquitin ligases via a synthetic biology approach in the budding yeast S. cerevisiae serves to elucidate turnover mechanisms. Secondly, expression vectors for so-called tandem fluorescent timer reporters shall be made and tested in plants. These vectors serve to investigate tissue- specificity and subcellular localization of turnover pathways. Candidates Successful candidates should have finished studies in Molecular Biology, Biochemistry or related (B. Sc.), and have 45 ECTS accomplished in the Master module. Interest in plant signal transduction and cellular homeostasis is advantageous. Duration: Ca. 12 months, starting Sep 2021 or later Payment: According to FWF payment scheme Contact: Univ.-Prof. Dr. Andreas Bachmair [email protected] Max Perutz Labs, Dept. of Biochemistry and Cell Biology, Univ. Wien Rm. 5110, Dr.-Bohr-Gasse 9, A-1030 Wien About the Max Perutz Labs The Max Perutz Labs are a research institute established by the University of Vienna and the Medical University of Vienna to provide an environment for excellent, internationally recognized research and education in the field of Molecular Biology. Dedicated to a mechanistic understanding of fundamental biomedical processes, scientists at the Max Perutz Labs aim to link breakthroughs in basic research to advances in human health.
    [Show full text]
  • Cytokines MONTRÉAL 2008
    Cytokines MONTRÉAL 2008 Translating Science into Health: Cytokines in Cancer, Infl ammation and Infectious Diseases 7th Joint Conference of the International Cytokine Society and the International Society for Interferon and Cytokine Research Photo: Tourisme Montréal Photo: Tourisme October 12-16, 2008 Fairmont Queen Elizabeth Hotel Montreal Quebec CANADA Cytokines Montreal 2008 1 PROGRAM From cell separation to molecular analysis The Gold Standard in Cell Isolation • Separation of functional, cytokine-secreting cells • Virtually any cell type from any species • Superior viability, purity and recovery Cytokines and Growth Factors • New, broad portfolio: human - mouse - rat • Excellent purity and activity • Optimized for cell culture applications MACSmolecular Tools for Molecular Analysis • Tools for signal transduction • State of the art microRNA analysis • Comprehensive gene expression profiling Unless otherwise specifically indicated, Miltenyi Biotec products and services are for research use only and not for therapeutic or diagnostic use. Miltenyi Biotec Inc. Phone 800 FOR MACS www.miltenyibiotec.com 12740 Earhart Avenue +1 530 888 8871 [email protected] Auburn CA 95602, USA Fax +1 530 888 8925 2 Cytokines Montreal 2008 ContentsWelcome to Montreal ..................................................................................... 4-5 Sponsors and Exhibitors ................................................................................... 6 Conference Venue ...........................................................................................
    [Show full text]
  • The Role of Polyadenylation in the Induction of Inflammatory Genes
    The role of polyadenylation in the induction of inflammatory genes Raj Gandhi BSc & ARCS Thesis submitted for the degree of Doctor of Philosophy September 2016 Declaration Except where acknowledged in the text, I declare that this thesis is my own work and is based on research that was undertaken by me in the School of Pharmacy, Faculty of Science, The University of Nottingham. i Acknowledgements First and foremost, I give thanks to my primary supervisor Dr. Cornelia de Moor. She supported me at every step, always made time for me whenever I needed it, and was sympathetic during times of difficulty. I feel very, very fortunate to have been her student. I would also like to thank Dr. Catherine Jopling for her advice and Dr. Graeme Thorn for being so patient and giving me so much help in understanding the bioinformatics parts of my project. I am grateful to Dr. Anna Piccinini and Dr. Sadaf Ashraf for filling in huge gaps in my knowledge about inflammation and osteoarthritis, and to Dr. Sunir Malla for help with the TAIL-seq work. I thank Dr. Richa Singhania and Kathryn Williams for proofreading. Dr. Hannah Parker was my “big sister” in the lab from my first day, and I am very grateful for all her help and for her friendship. My project was made all the more enjoyable/bearable by the members of the Gene Regulation and RNA Biology group, especially Jialiang Lin, Kathryn Williams, Dr. Richa Singhania, Aimée Parsons, Dan Smalley, and Hibah Al-Masmoum. Barbara Rampersad was a wonderful technician. Mike Thomas, James Williamson, Will Hawley, Tom Upton, and Jamie Ware were some of the best of friends I could have hoped to make in Nottingham.
    [Show full text]
  • The Serials Crisis and Open Access: a White Paper for the Virginia Tech Commission on Research
    The Serials Crisis and Open Access A White Paper for the Virginia Tech Commission on Research Philip Young University Libraries Virginia Tech December 2, 2009 This work is licensed under a Creative Commons Attribution-Noncommercial-Share Alike 3.0 United States License. 1 Introduction This white paper offers an introduction to open access as well as a look at its current development. The open access movement is an attempt to free scholarly communication from restrictions on access, control, and cost, and to enable benefits such as data mining and increased citations. Open access has gained significant momentum through mandates from research funders and universities. While open access can be provided in parallel with traditional publishing, it is increasingly available as a publishing option. While open access is approached here from the problem of subscription inflation, it is important to recognize that open access is not merely a library issue, but affects the availability of research to current and future students and scholars. The Serials Crisis The phrase “serials crisis” has been in use for more than a decade as shorthand for the rise in costs for academic journals and the inability of libraries to bring these costs under control. Price inflation for academic journals significantly exceeds the consumer price index (see graph, next page). The most recent data show that journal prices increased at an average rate of 8% in 2007.1 Because journal subscriptions are a large part of the collections budget at academic libraries, any reduction in funding usually results in a loss of some journals. And the high rate of annual inflation means that academic library budgets must increase every year simply to keep the same resources that students and faculty need.
    [Show full text]
  • Contents and Society
    8 EMBL August 2001 &cetera Newsletter of the European Molecular Biology Laboratory published by the Office of Information and Public Affairs EMBL appoints heads for Hinxton and Monterotondo MBLhas appointed new heads of the EBI in Hinxton and the A priority for both scientists will be to boost research activities at EMouse Biology Programme in Monterotondo. Nadia their units. Past funding limitations have prevented the EBI from Rosenthal, Associate Professor at Harvard and consulting editor developing a full research programme, although there have been at the New England Journal of Medicine, has taken charge of the a few very active groups since the site was opened. New funds Mouse Biology Programme, assuming the post vacated by Klaus from the EMBL member states will permit the addition of a full Rajewsky in June. Janet Thornton, Professor at the University complement of research teams, just as Cameron and his col- College of London and Fellow of the Royal Society, will direct leagues have been extremely successful in obtaining major fund- activities at the EBI, especially research. She succeeds Michael ing from the EC and the Wellcome Trust to bolster the EBI data- Ashburner, who has served as Co-Head of the Institute alongside bases and related services. Graham Cameron since the EBI was launched five years ago. Monterotondo, which opened in 1999, has been waiting for the "The new five-year scientific plan at EMBL stresses functional g reen light from EMBL's Council to reach critical mass. genomics and foresees substantial expansion of the EBI and the Rosenthal’s appointment comes at a time when a partner on the Mouse Biology Programme at Monterotondo," says Director Monterotondo campus, the European Mutant Mouse Archive General Fotis C.
    [Show full text]
  • The European Molecular Biology Organization (EMBO) and Nature
    The European Molecular Biology Organization (EMBO) and Nature Publishing Group (NPG) are pleased to announce that The EMBO Journal and EMBO reports will accept open-access articles as of January 2007, subject to payment of a publication fee. The journals are moving to a mixed-revenue model of subscription charges and publication fees. The open-access option will be available to all authors submitting original research on or after 1 January 2007. The publication fee will be €2,000 plus VAT (where applicable). Articles published with a publication fee will be clearly identified in the online and print editions of the journal with an open-access icon. Print subscription prices will not be affected and site license prices will be adjusted in line with the amount of subscription content published annually. The journal editors will be blind to the author's choice, avoiding any possibility of a conflict of interest during peer review and acceptance. Authors paying the publication fee will be entitled to self-archive the published version immediately on publication in a repository of their choice, and in any format. Content that an author has decided to make freely available online will be licensed under the Creative Commons Deed 2.5 (http://creativecommons.org/licenses/by-nc-nd/2.5/). The author thereby permits dissemination and re-use of the article, enabling the sharing and re-use of scientific material. This does not however permit commercial exploitation or the creation of derivative works without specific permission. Other articles will continue to be published under NPG’s exclusive License-to-Publish, where its usual self-archiving policy will apply.
    [Show full text]
  • Assistant Professor in Molecular Biology According to § 99 (5) University Law 2002 (UG) Is Announced
    At the Medical University of Vienna a position as Assistant Professor in Molecular Biology according to § 99 (5) University Law 2002 (UG) is announced. The Medical University of Vienna is one of Europe’s premiere institutions for biomedical and clinical research. We are looking for a highly qualified scientist in the field of Molecular Biology with enthusiasm for inter- and multi-disciplinary research, and commitment to teaching. The Max Perutz Labs (https://maxperutzlabs.ac.at), a joint venture of the University of Vienna and the Medical University of Vienna, are seeking a tenure track junior group leader with outstanding potential to establish an independent and internationally competitive research group. The mission of the Max Perutz Labs is to catalyze discovery in mechanistic biomedicine with an emphasis on analyzing and reconstituting biological processes from atomic to tissue and organismal scales. The successful candidate will bring ambition and creativity to tackle fundamental biological questions that have the potential to impact human health. Your profile: • Completed scientific or medical education with PhD or equivalent degree. • International recognition in the respective research area. • Successful and continuous acquisition of peer-reviewed third-party funding. • Educational and didactic qualifications including supervision of Masters and PhD students. • Diversity and gender competence. • International working experience We offer: The successful candidate will be offered an Assistant Professor position for a maximum duration of six years. Should the candidate meet the conditions stipulated in the qualification agreement, she/he will be promoted to tenured Associate Professor. Conditions and criteria are defined in the official career track guidelines of the university (Career scheme for the scientific University staff according to §99 Abs.
    [Show full text]
  • EMBO Facts & Figures
    excellence in life sciences Reykjavik Helsinki Oslo Stockholm Tallinn EMBO facts & figures & EMBO facts Copenhagen Dublin Amsterdam Berlin Warsaw London Brussels Prague Luxembourg Paris Vienna Bratislava Budapest Bern Ljubljana Zagreb Rome Madrid Ankara Lisbon Athens Jerusalem EMBO facts & figures HIGHLIGHTS CONTACT EMBO & EMBC EMBO Long-Term Fellowships Five Advanced Fellows are selected (page ). Long-Term and Short-Term Fellowships are awarded. The Fellows’ EMBO Young Investigators Meeting is held in Heidelberg in June . EMBO Installation Grants New EMBO Members & EMBO elects new members (page ), selects Young EMBO Women in Science Young Investigators Investigators (page ) and eight Installation Grantees Gerlind Wallon EMBO Scientific Publications (page ). Programme Manager Bernd Pulverer S Maria Leptin Deputy Director Head A EMBO Science Policy Issues report on quotas in academia to assure gender balance. R EMBO Director + + A Conducts workshops on emerging biotechnologies and on H T cognitive genomics. Gives invited talks at US National Academy E IC of Sciences, International Summit on Human Genome Editing, I H 5 D MAN 201 O N Washington, DC.; World Congress on Research Integrity, Rio de A M Janeiro; International Scienti c Advisory Board for the Centre for Eilish Craddock IT 2 015 Mammalian Synthetic Biology, Edinburgh. Personal Assistant to EMBO Fellowships EMBO Scientific Publications EMBO Gold Medal Sarah Teichmann and Ido Amit receive the EMBO Gold the EMBO Director David del Álamo Thomas Lemberger Medal (page ). + Programme Manager Deputy Head EMBO Global Activities India and Singapore sign agreements to become EMBC Associate + + Member States. EMBO Courses & Workshops More than , participants from countries attend 6th scienti c events (page ); participants attend EMBO Laboratory Management Courses (page ); rst online course EMBO Courses & Workshops recorded in collaboration with iBiology.
    [Show full text]
  • Master Position in Plant Molecular Biology
    Bachmair lab Master position in plant molecular biology A Master Thesis position is available in the Bachmair group (Max Perutz Labs), starting Dec 2020 or later. Topic A) Analysis of plant ubiquitin ligases via a synthetic biology approach in the budding yeast S. cerevisiae. We are analyzing protein turnover in plants that depends on amino-terminal degradation signals. Expression of the involved enzymes in yeast is part of mechanistic studies on these turnover pathways. B) Construction of expression vectors for novel reporter proteins (tandem fluorescent timer constructs). The vectors shall serve for analysis of half-life and subcellular localization of fused proteins. The constructs shall be tested in the model plant, A. thaliana. Focus of the Bachmair lab lies on the biochemical and cell biological analysis of protein turnover driven by amino-terminal degradation signals. The biological context is how plants respond to environmental stimuli such as heat, flooding or salt stress. Additional information can be found on the Bachmair lab web site (contact address below). Application Requirements: Finished study (B. Sc.) in Molecular Biology, Biochemistry or related, 45 ECTS accomplished in the Master module Duration: ca. 12 months Payment: acc. to FWF rates Contact: [email protected] Univ.-Prof. Dr. Andreas Bachmair Max Perutz Labs, Dept. of Biochemistry and Cell Biology, University of Vienna Rm. 5110, Dr.-Bohr-Gasse 9, A-1030 Wien https://www.maxperutzlabs.ac.at/research/research-groups/bachmair MAX PERUTZ LABS A joint venture of Part of Vienna BioCenter (VBC) • Dr.-Bohr-Gasse 9 • 1030 Vienna Tel: +43 1 4277 24001 • [email protected] www.maxperutzlabs.ac.at Recent publications (Bachmair lab) Millar, A.
    [Show full text]
  • Peakmatcher: Matching Peaks Across Genome Assemblies
    PeakMatcher: Matching Peaks Across Genome Assemblies Ronald J. Nowling Christopher R. Beal Scott Emrich Milwaukee School of Engineering Marquette University University of Tennessee–Knoxville Milwaukee, Wisconsin Milwaukee, Wisconsin Knoxville, Tennessee [email protected] [email protected] [email protected] Susanta K. Behura Marc S. Halfon Molly Duman-Scheel University of Missouri SUNY at Buffalo Indiana University School of Medicine Columbia, Missouri Buffalo, New York South Bend, Indiana [email protected] [email protected] [email protected] ABSTRACT The second data set was STARR-Seq (Self-Transcribing Active When reference genome assemblies are updated, the peaks from Regulatory Region Sequencing) of Drosophila melanogaster DNA DNA enrichment assays such as ChIP-Seq and FAIRE-Seq need in S2 culture cells [1]. We called STARR peaks against two versions to be called again using the new genome assembly. PeakMatcher (dm3 and r5.53) of the D. melanogaster genome [6]. PeakMatcher is an open-source package that aids in validation by matching matched 77.4% (precision) of the 4,195 dm3 peaks with 94.8% (recall) peaks across two genome assemblies using the alignment of reads of the 3,114 r5.53 peaks. or within the same genome. PeakMatcher calculates recall and PeakMatcher and associated documentation are available on precision while also outputting lists of peak-to-peak matches. GitHub (https://github.com/rnowling/peak-matcher) under the open- PeakMatcher uses read alignments to match peaks across genome source Apache Software License v2. PeakMatcher was written in assemblies. PeakMatcher finds all read aligned to one genome that Python 3 using the intervaltree library.
    [Show full text]
  • Chromatin and Epigenetics Cross-Journal Focus Chromatin and Epigenetics
    EMBO Molecular Medicine cross-journal focus Chromatin and epigenetics cross-journal focus Chromatin and epigenetics EDITORS Esther Schnapp Senior Editor [email protected] | T +49 6221 8891 502 Esther joined EMBO reports in October 2008. She was awarded her PhD in 2005 at the Max Planck Institute for Molecular Cell Biology and Genetics in Dresden, Germany, where she studied tail regeneration in the axolotl. As a post-doc she worked on muscle development in zebrafish and on the characterisation of mesoangioblasts at the Stem Cell Research Institute of the San Raffaele Hospital in Milan, Italy. Anne Nielsen Editor [email protected] | T +49 6221 8891 408 Anne received her PhD from Aarhus University in 2008 for work on miRNA processing in Joergen Kjems’ lab. As a postdoc she then went on to join Javier Martinez’ lab at IMBA in Vienna and focused on siRNA-binding proteins and non-conventional splicing in the unfolded protein response. Anne joined The EMBO Journal in 2012. Maria Polychronidou Editor [email protected] | T +49 6221 8891 410 Maria received her PhD from the University of Heidelberg, where she studied the role of nuclear membrane proteins in development and aging. During her post-doctoral work, she focused on the analysis of tissue-specific regulatory functions of Hox transcription factors using a combination of computational and genome-wide methods. Céline Carret Editor [email protected] | T +49 6221 8891 310 Céline Carret completed her PhD at the University of Montpellier, France, characterising host immunodominant antigens to fight babesiosis, a parasitic disease caused by a unicellular EMBO Apicomplexan parasite closely related to the malaria agent Plasmodium.
    [Show full text]
  • 2008-05-13-Professors Marc Feldmann and Sir Ravinder Maini
    Contact: Seema Kumar Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (908) 218-6460 or [email protected] Frederik Wittock Johnson & Johnson Pharmaceutical Research & Development (Belgium) +32 14 60 57 24 or [email protected] Professors Marc Feldmann and Sir Ravinder Maini Named Winners of the 2008 Dr. Paul Janssen Award for Biomedical Research New York, N.Y. – May 13, 2008 – Johnson & Johnson today announced that Professor Marc Feldmann, FMedSci, FAA, FRS and Emeritus Professor Sir Ravinder N. Maini, FRCP, FMedSci, FRS of the Kennedy Institute of Rheumatology, Imperial College London have been named the recipients of the 2008 Dr. Paul Janssen Award for Biomedical Research by an independent selection committee of world-renowned scientists. The award salutes the most passionate and creative scientists in basic or clinical research, whose scientific achievements have made, or have strong potential to make, a measurable impact on human health. Feldmann and Maini were selected for their role in the discovery of tumor necrosis factor-alpha, or TNF-alpha, as an effective therapeutic target for rheumatoid arthritis and other chronic inflammatory conditions afflicting millions worldwide. The award, which includes a $100,000 prize, will be presented to the winners at events in New York and Beerse, Belgium in September. According to Solomon Snyder, Ph.D., Distinguished Service Professor of Neuroscience, Pharmacology and Psychiatry, Johns Hopkins School of Medicine and Chairman, Janssen Award Selection Committee, “The work of Feldmann and Maini exemplifies the bench-to-bedside approach that Paul Janssen’s contributions epitomized. It is extremely rare for researchers to identify a molecular messenger in test tube studies, demonstrate its physiologic relevance in animals and themselves carry these efforts forward to a successful clinical demonstration.
    [Show full text]